Eli Lilly sees U.S. prasugrel filing next week
35880
Eli Lilly and Co  plans to  submit a U.S. application next week for its experimental  blood-clot preventer prasugrel, the most important drug in its  pipeline, a company spokesman said on Wednesday.
729020
Eli Lilly and Co. LLY.N on Thursday  said that it expects 2005 earnings to rise as higher sales of  its newer drugs offset a decline in its top-selling  schizophrenia drug Zyprexa.
34706
Drug maker Eli Lilly and Co.  on Friday said in response to charges made in the British Medical Journal that it is unaware of any allegations that documents were missing from its clinical drug trials.
591674
Bristol-Myers Squibb (nyse: BMY - news - people ) will report third-quarter earnings. Analysts surveyed by Thomson First Call expect the pharmaceutical maker to earn 39 cents per share compared with 47 cents a year ago.
439056
The generics drugmaker forecasts its 2008 financials.
293341
Biogen Idec Inc.&#39;s Tysabri drug for multiple sclerosis may reach patients as soon as next week, and doctors said they plan to prescribe it first to patients who are no longer being helped by older medicines.
301891
Pfizer Inc. is on schedule to complete the filing of 20 new drug applications by the end of 2006 as it confronts patent expirations affecting $14 billion in sales, CEO Hank McKinnell said Tuesday.
705384
Drugmaker Eli Lilly and Co. (LLY.N: Quote, Profile, Research) on Wednesday said it will make clinical trial information available online amid calls by lawmakers and physicians for more disclosure of negative trial results.
260262
Pfizer Inc, Novartis AG and Wyeth all saw quarterly earnings hit by charges on Thursday, while Eli Lilly and Co exceeded Wall Street expectations as third-quarter sales of several of its drugs outpaced analysts' estimates.
381456
Eli Lilly & Co  and Japan's  Daiichi Sankyo Co Ltd (4568.T) said on Friday they had asked  U.S. regulators to approve prasugrel, a blood clot preventer  that is the U.S. drug maker's most important experimental  product.
526091
Drugmaker Eli Lilly and Co. LLY.N on  Wednesday said its restructuring will result in a  fourth-quarter charge of 24 cents to 27 cents per share, above  its previous estimate of 19 to 24 cents per share.
90458
The move comes ahead of a House hearing this week where, it is expected, drug companies will be excoriated for refusing to publish unfavorable clinical trial results.
741054
Eli Lilly and Co. LLY.N on Thursday  said its third-quarter earnings rose as growing demand for its  medicines offset higher spending to market recently approved  treatments.
615212
Eli Lilly and Co. LLY.N on Thursday  said it expects earnings in 2005 to rise to between $3.05 and  $3.15 per share before special items as growing sales of newer  medicines more than offset disappointing sales of its  top-selling schizophrenia drug.
333819
Company says FDA has approved Cymbalta, OK&#39;d last month as antidepression, to treat diabetic pain. NEW YORK  - Eli Lilly and Co.
505571
The US Food and Drug Administration expects to inspect Boston Scientific Corp.&#39;s Galway, Ireland factory in the &quot;near future&quot; as part of its probe into the company&#39;s coronary stent recall, the Wall Street Journal said on Friday.
527244
Beds and meds will color in the week that lies ahead.